MEPD after TT insertion
TT 插入后的 MEPD
基本信息
- 批准号:7657385
- 负责人:
- 金额:$ 17.33万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-08-01 至 2011-07-31
- 项目状态:已结题
- 来源:
- 关键词:3 year oldBolus InfusionBypassChildClinicalClinical ResearchConditionConstitutionalDataDiseaseEarEconomic InflationEdemaEnrollmentEquilibriumEustachian TubeFeedbackFrequenciesFunctional disorderGasesHealedHumanIndividualInflammationLongitudinal StudiesMeasurementMeasuresMedicalMethodsModelingMucous MembraneNoble GasesOtitis MediaOtitis Media with EffusionOtorrheaPathogenesisPatient observationPatientsPhaseProtocols documentationRateRecurrenceRegulationResearch PersonnelResolutionRiskSolidTestingTimeTubeTympanostomyTympanostomy Tube Insertionsagedconceptdisorder preventioneffusionexpectationhealingmathematical modelmiddle earpressurepreventprogramstheories
项目摘要
MIDDLE EAR PRESSURE DEREGULATION AFTER TYMPANOSTOMY TUBE INSERTION
Perhaps the most well supported clinical evidence for our model of Otitis Media with Effusion (OME)
pathogenesis by middle ear (ME) pressure disregulation is the documented positive effect of tympanostomy tube
(TT) insertion in preventing and resolving OME episodes. Because TTs bypass the Eustachian tube (ET) to
maintain ambient ME pressure, these observations suggest that adequate ME pressure-regulation and not other
suggested functions of the ET is prerequisite for disease resolution. Longitudinal studies show that after TT
insertion in MEs with OME, the volume of the ME airspace progressively increases which correlates with
decreasing ME inflammation and effusion volume. Our mathematical model shows that these changes should
be reflected as lesser rates of gas exchange across the ME mucosa which are realized as a decreased demand
placed upon the ET for gas resupply. In the proposed study, we will enroll children aged 3 years and older with
TTs inserted for OME and measure the ME gas demand, ME volume and ETF longitudinally between TT
insertion and extrusion, and then follow the enrolled patients for disease recurrence after TT extrusion. These
results will be used to test the hypotheses that: 1) gas transfer across the ME mucosa (MEM) decreases in
phase with resolution of ME inflammation and effusion; 2) gas transfer across the MEM is increased by an
episode of otorrhea; 3) ETF is unaffected by TT insertion, and 4) measurement of ETF and transMEM gas
transfer (supply/demand balance) predicts disease recurrence and presentation after TT extrusion. The results
of these studies will be used to support or refute tested components of our model of ME pressure-regulation and
to develop test protocols for risk assignments with respect to disease recurrence in individual ears after TT
extrusion.
插入鼓膜造口管后中耳压力放松
也许是我们的渗出性中耳炎 (OME) 模型最有力的临床证据
中耳 (ME) 压力失调的发病机制是鼓膜造口管的积极作用
(TT) 插入预防和解决 OME 事件。因为 TT 绕过咽鼓管 (ET)
维持环境 ME 压力,这些观察结果表明,充分的 ME 压力调节而不是其他
ET 的建议功能是疾病解决的先决条件。纵向研究表明,TT 后
通过 OME 插入 ME,ME 空域的体积逐渐增加,这与
减少 ME 炎症和渗出量。我们的数学模型表明这些变化应该
反映为穿过 ME 粘膜的气体交换率较低,这是由于需求减少而实现的
放置在 ET 上进行气体补给。在拟议的研究中,我们将招募 3 岁及以上的儿童
为 OME 插入 TT,并在 TT 之间纵向测量 ME 气体需求、ME 量和 ETF
插入和拔出,然后跟踪入组患者 TT 拔出后的疾病复发情况。这些
结果将用于检验以下假设:1) 穿过 ME 粘膜 (MEM) 的气体传输减少
ME 炎症和渗出消退阶段; 2)通过MEM的气体传输增加了
耳漏发作; 3) ETF 不受 TT 插入的影响,4) ETF 和 transMEM 气体的测量
转移(供需平衡)可预测 TT 挤出后疾病的复发和表现。结果
这些研究中的一部分将用于支持或反驳我们的 ME 压力调节模型的测试组件
制定 TT 后个体耳朵疾病复发风险分配的测试方案
挤压。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ELLEN M MANDEL其他文献
ELLEN M MANDEL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ELLEN M MANDEL', 18)}}的其他基金
SYSTEMIC STEROID FOR CHRONIC OTITIS MEDIA WITH EFFUSION
全身类固醇治疗慢性渗出性中耳炎
- 批准号:
2126718 - 财政年份:1994
- 资助金额:
$ 17.33万 - 项目类别:
SYSTEMIC STEROID FOR CHRONIC OTITIS MEDIA WITH EFFUSION
全身类固醇治疗慢性渗出性中耳炎
- 批准号:
2126719 - 财政年份:1994
- 资助金额:
$ 17.33万 - 项目类别:
SYSTEMIC STEROID FOR CHRONIC OTITIS MEDIA WITH EFFUSION
全身类固醇治疗慢性渗出性中耳炎
- 批准号:
2126720 - 财政年份:1994
- 资助金额:
$ 17.33万 - 项目类别:
MYRINGOTOMY WITH/WITHOUT TYMPANOSTOMY TUBE FOR OTITIS MEDIA WITH EFFUSION
鼓膜切开术(带/不带鼓室置管管)用于治疗有渗出性中耳炎
- 批准号:
3896581 - 财政年份:
- 资助金额:
$ 17.33万 - 项目类别:
MYRINGOTOMY WITH/WITHOUT TYMPANOSTOMY TUBE FOR OTITIS MEDIA WITH EFFUSION
鼓膜切开术(带/不带鼓室置管管)用于治疗有渗出性中耳炎
- 批准号:
3923028 - 财政年份:
- 资助金额:
$ 17.33万 - 项目类别:
相似海外基金
Glucagon Pump Therapy for Post-Bariatric Hypoglycemia: Merging Physiology and Engineering
胰高血糖素泵治疗减肥后低血糖:生理学与工程学的结合
- 批准号:
10754041 - 财政年份:2023
- 资助金额:
$ 17.33万 - 项目类别:
Toxicology and Efficacy Studies of Intrathecal VersaMab-101 for spinal cord injury treatment
鞘内注射 VersaMab-101 治疗脊髓损伤的毒理学和疗效研究
- 批准号:
10697262 - 财政年份:2023
- 资助金额:
$ 17.33万 - 项目类别:
Formulation and pharmacokinetics of subcutaneous administration of deferiprone for prevention of chronic heart failure following hemorrhagic myocardial infarction.
皮下注射去铁酮预防出血性心肌梗死后慢性心力衰竭的配方和药代动力学。
- 批准号:
10700370 - 财政年份:2023
- 资助金额:
$ 17.33万 - 项目类别:
Title: Development and Validation of Therapy for GM1 Gangliosidosis
标题:GM1 神经节苷脂沉积症疗法的开发和验证
- 批准号:
10678309 - 财政年份:2023
- 资助金额:
$ 17.33万 - 项目类别:
Supplemental Citicoline Administration for Reduction of Lung Injury Efficacy Trial (SCARLET)
补充胞二磷胆碱减少肺损伤疗效试验(SCARLET)
- 批准号:
10657726 - 财政年份:2022
- 资助金额:
$ 17.33万 - 项目类别: